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correlated strongly with osmolality after the exposure 
(r = 0.70, P = 0.004). In volunteers with maximum 
Tc > 38 °C (n = 8) vs ≤ 38 °C (n = 7) there were significantly 
greater elevations in copeptin (10.4 vs. 2.4 pmol L−1) and 
creatinine (10 vs. 2 μmol L−1), but no differences in cortisol, 
free normetanephrine or osmolality.
Conclusions Changes in copeptin reflected Tc response 
more closely than sympathoadrenal markers or osmolal-
ity. Dynamic relationships with tonicity and kidney func-
tion may help to explain this finding. As a surrogate for 
integrated physiological strain during work in a field envi-
ronment, copeptin assay could inform future measures to 
prevent heat-related illnesses.
Keywords Dehydration · Heat illness · Acute kidney 
injury · Arginine vasopressin · Normetanephrine · Cortisol
Abbreviations
ANOVA  Analysis of variance
AUC-Tc37  Area under the core body temperature–time 
curve (baseline Tc 37 °C)
AVP  Arginine vasopressin
LT38  Volunteers with maximum Tc 
observed ≤ 38.0 °C
GFR  Glomerular filtration rate
GPS  Global positioning system
GT38  Volunteers with maximum observed 
Tc > 38.0 °C
PRE  Before assault exposure
POST  After assault exposure
sCr  Serum creatinine
SD  Standard deviation
Tc  Core body temperature
TcMax  Maximum observed Tc
WBGT  Wet bulb globe temperature
Abstract 
Purpose To prevent heat-related illnesses, guidelines rec-
ommend limiting core body temperature (Tc) ≤ 38 °C during 
thermal stress. Copeptin, a surrogate for arginine vasopres-
sin secretion, could provide useful information about fluid 
balance, thermal strain and health risks. It was hypothesised 
that plasma copeptin would rise with dehydration from 
occupational heat stress, concurrent with sympathoadrenal 
activation and reduced glomerular filtration, and that these 
changes would reflect Tc responses.
Methods Volunteers (n = 15) were recruited from a British 
Army unit deployed to East Africa. During a simulated com-
bat assault (3.5 h, final ambient temperature 27 °C), Tc was 
recorded by radiotelemetry to differentiate volunteers with 
maximum Tc > 38 °C versus ≤ 38 °C. Blood was sampled 
beforehand and afterwards, for measurement of copeptin, 
cortisol, free normetanephrine, osmolality and creatinine.
Results There was a significant (P < 0.05) rise in copeptin 
from pre- to post-assault (10.0 ± 6.3 vs. 16.7 ± 9.6 pmol L−1, 
P < 0.001). Although osmolality did not increase, copeptin 
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Introduction
Individuals who perform strenuous work are at risk of 
adverse effects associated with excessive body heat (‘heat 
illness’), varying from physical incapacity to severe injury 
and death (Armstrong et al. 2007). A widely accepted defini-
tion of heat stroke is as ‘a form of hyperthermia associated 
with a systemic inflammatory response, leading to a syn-
drome of multiorgan dysfunction in which encephalopathy 
predominates’ (Leon and Bouchama 2015).
To minimise the incidence of heat illness, occupational 
guidelines recommend that core body temperature (Tc) is 
maintained at or below 38.0 °C. Despite these guidelines, 
Tc exceeds 38.0 °C during a number of occupational activi-
ties (Meade et al. 2016). There are considerable practical 
limitations to rectal or intra-gastric Tc monitoring and sam-
pling at the tympanic membrane may be unhelpful, due to 
lack of uniformity of the temperature response (Yeoh et al. 
2017) and the potential for hearing and thus safe working 
to be affected. Furthermore, the inter-individual response 
to thermal stress is diverse; the exact significance of core 
temperature in the pathophysiology of heat stroke remains 
debated (Noakes 2008); and evidence from civilian occu-
pational settings (Garzon-Villalba et al. 2016) and military 
training (Wallace et al. 2005) indicates a cumulative effect 
of prior-day thermal stress on risk of heat-related illnesses. 
Thus instantaneous Tc values may incompletely reflect the 
risk of heat illness. A marker that integrates the physiologi-
cal strain incurred during thermal stress, including but not 
limited to Tc response, could prove useful in prospectively 
identifying which individuals exposed to the same working 
conditions will become casualties.
The posterior pituitary hormone arginine vasopressin 
(AVP) classically rises in response to hypovolaemia and 
increasing osmolality, and is secreted as a large peptide pre-
cursor ProAVP. ProAVP consists of AVP, copeptin, neuro-
physin II and a signal peptide. With exertion in a warm envi-
ronment, AVP has been shown to relate closely to plasma 
osmolality (Montain et al. 1997), which is a preferred blood 
marker of dehydration from thermal sweating (Cheuvront 
and Kenefick 2014). Thus an index of AVP secretion could 
usefully reflect physiological strain under thermal stress.
The assay of AVP itself is highly problematic (it is 
labour intensive, requires multiple pre-analytical steps, 
has a half-life < 30 min and is unstable even in isolated 
plasma), therefore recently copeptin (which is stable and 
can be measured on an automated analyser) has found 
favour as a valid and practical surrogate for AVP secre-
tion (Morgenthaler 2012; Christ-Crain and Fenske 2016). 
Copeptin secretion occurs in response to various stressors 
(Christ-Crain and Fenske 2016; Katan et al. 2008a, b) and 
its concentration in peripheral blood has been proposed 
as a sensitive marker of the individual stress level (Katan 
et al. 2008a). In healthy subjects performing a high alti-
tude trek, plasma concentrations of copeptin and AVP 
associated closely and the correlation was strengthened 
(r = 0.834, p < 0.001) at the highest and most stressful 
measurement point (Mellor et al. 2015). In disease, copep-
tin has been found to be of prognostic value in diverse 
conditions such as sepsis (Seligman et al. 2008), septic 
and haemorrhagic shock (Morgenthaler et al. 2007), lower 
respiratory tract infections (Müller et al. 2007), cardio- 
and cerebrovascular disease (Sun et al. 2015; Stoiser et al. 
2006; Marston et al. 2016; Greisenegger et al. 2015) and 
for end stage renal failure, coronary heart disease and all-
cause mortality in patients with type 1 diabetes (Velho 
et al. 2016).
One important factor that may contribute to AVP/
copeptin release is body temperature. Enhanced secretion 
of AVP with increasing tissue temperature has been dem-
onstrated both in resting human subjects (Takamata et al. 
1995a) and in hypothalamic-pituitary explants warmed 
from 37.0 to 39.5 °C (Sladek and Johnson 2013), whereby 
the rise in AVP was additive with that from increasing 
osmolality of plasma/perfusate. The effect of Tc on copep-
tin concentration is yet to be investigated, however, and 
relationships of copeptin with other parameters of physi-
ological strain under thermal stress have not been charac-
terised. We hypothesised that plasma copeptin would rise 
with dehydration from occupational heat stress, concur-
rent with serum osmolality and creatinine (sCr), and that 
changes in copeptin would reflect Tc response. As a Tc of 
38.0 °C marks an important thermoregulatory threshold 
during exertional heat stress (Commission for Thermal 
Physiology 1987) above which vasomotor compensation 
plateaus (Gonzalez-Alonso et al. 1999) and sensitive con-
trol of Tc is lost (Wyndham et al. 1965) we chose a Tc 
of 38.0 °C as a threshold for the initial investigation of 
copeptin in response to thermal stress. As sympathoadre-
nal activation is augmented by Tc rise (Rhind et al. 1999), 
we additionally investigated changes in cortisol and free 
normetanephrine levels as alternative markers of physi-
ological strain under heat stress.
Methods
Ethical approval
This study was approved by the United Kingdom (UK) 
Ministry of Defence Research Ethics Committee (465/
MODREC/13) and complied with the standards set in 
the Declaration of Helsinki. All volunteers gave written 
informed consent.
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Study design
Preliminary measures
Volunteers were recruited to the study from a British Army 
infantry battalion who took part in an overseas military 
exercise in northern Kenya (East Africa). A total of fifteen 
volunteers completed study measures in the deployed field 
environment.
Prior to departure, volunteers underwent baseline meas-
urements at their home duty station in the UK. A digital 
scale and stadiometer (SECA Ltd, Leicester, UK) were used 
to determine body mass, to the nearest 0.01 kg, and height, 
to the nearest 0.1 cm, while wearing the clothing ensemble 
to be worn in Kenya, minus boots. Body fat as a percentage 
of body composition was determined by segmental multi-
frequency bioimpedance (Tanita UK Ltd., Yiewsley, Mid-
dlesex, UK).
Deployed measures
The volunteers deployed to Kenya 3 weeks after baseline 
measurements, where they undertook low-level activi-
ties in cooler upland environs. Environmental conditions 
were monitored locally using a wet bulb globe temperature 
(WBGT) monitor (Grant, Cambridge, UK) throughout. 
Average WBGT was 16 °C during this initial phase, which 
lasted for 3 weeks. They then re-located to a warm lowland 
environment to take part in simulated combat assaults con-
ducted over varying terrain while on foot, with live firing of 
munitions. Volunteers wore full combat dress and carried 
an equipment load of 38.9 ± 5.0 kg. The WBGT during this 
phase was 26 ± 5 °C.
Deployed study measures were made in relation to a 
simulated combat assault on the morning of the sixth day 
of training in the warm environment, 6 weeks following 
the UK measures. Volunteers rose from overnight rest-
ing at 2.00 a.m. local time and underwent study measures 
in a 1 h sampling window (2.30 a.m.–3.30 a.m.). They 
were weighed by digital scale, to the nearest 0.01  kg 
(SECA Ltd, Leicester, UK), provided pre-assault (PRE) 
blood samples and had a plastic sweat-collection pouch 
applied to the left upper arm. Volunteers were then trans-
ported by vehicle to the training area, where they rested 
(5.00 a.m.–7.00 a.m.) until moving into position for the 
start of the assault (7.00 a.m.–7.30 a.m.). The field assault 
lasted for 3.5 h, from 8.00 a.m. to 11.30 a.m. It consisted 
of a staggered advance on foot into a series of ‘enemy’ 
defensive positions in a mock-up village, with intermittent 
static periods of co-ordinated weapon firing, re-grouping 
and re-supply (including drinking water). Post-assault 
(POST) blood samples were drawn after the conclusion 
of the assault, between 30 and 60 min following cessation 
of strenuous exertion (12.00 p.m.–12.30 p.m.). Where still 
intact, sweat was sampled from the collection pouch. Vol-
unteers were allowed to drink water only, from rising until 
the completion of POST measures (2.00 a.m.–12.30 p.m.).
For Tc monitoring, each volunteer was provided with 
two telemetric pills (VitalSense, Mini Mitter Company 
Inc, Oregan, USA) to ingest 12 and 2 h before the field 
assault (6.00 p.m. and 6.00 a.m.). This was with the inten-
tion of using measurements from the pill that had been in 
the gastrointestinal tract for the longest period, in order 
to reduce confounding from the ingestion of water dur-
ing the assault, while allowing for the possibility that 
the first ingested pill could be excreted before the end of 
the monitoring period. These transmitted wirelessly to a 
receiver (VitalSense, Mini Mitter Company Inc, Oregan, 
USA) carried on the volunteer’s person, which logged Tc 
locally every 60 s during the field assault. A member of 
each sub-unit within the group (n = 4) carried a Global 
Positioning System (GPS) (Sportslog, UK), which also 
logged locally every 60 s.
Biochemical sampling and processing
Blood was obtained by venesection in rested volunteers 
in a seated position from an antecubital fossa vein. Blood 
was drawn into in a serum separator tube (SST) (cortisol, 
osmolality and creatinine) and EDTA tube (plasma copep-
tin and free normetanephrine). Samples were stored in ice 
and centrifuged within 1 h. With sweat samples, they were 
then immediately frozen to −20 °C and maintained at this 
temperature during transportation back to the UK, where 
they were stored at −80 °C until analysis. All measurements 
were performed in duplicate. Copeptin was assayed using 
an automated sandwich immunofluorescent assay based on 
TRACE technology (Brahms CT-proAVP Kryptor Compact 
Plus, Hennigsdorf, Germany). This assay has a coefficient 
of variation (CV) of 2.5–3.7% and a lower limit of detection 
of 0.9 pmol L−1. Cortisol was measured using the Roche 
Elecsys Cortisol I assay, an automated competitive chemilu-
minescence immunoassay (CLIA), using the Roche modular 
E unit (Roche Diagnostics, Burgess Hill, UK). The analytical 
range of the assay is 0.5–1750 nmol L−1 and the intra-assay 
CV is 9.3–11.7%. Free normetanephrine was measured using 
an in-house liquid chromatography/tandem mass spectrom-
etry method (CV 4–12%). Osmolality was measured using 
a depression of freezing point method  (Advanced® Model 
3320 Micro-Osmometer, Advanced Instruments, Norwood, 
MA, USA) with a CV of 1.1%. Creatinine was measured 
using the Jaffe method (CV 1.7–2.3%). Sweat sodium con-
centration was measured by an automated indirect ion selec-
tive electrode (ISE) method, with a lower limit of quantifi-
cation of 20 mmol L−1 and an inter-assay CV of 1.7–4.6%.
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Sample size
A power calculation was not performed prospectively as the 
sample size was dictated by the availability of equipment 
and personnel during a busy infantry exercise in a remote 
environment, in the face of significant logistic challenges. It 
was noted, however, that Morgenthaler et al. (2006) showed 
a significant, near two-fold increase in copeptin concentra-
tions in a sample of 12 volunteers performing bicycle exer-
cise (ambient conditions and Tc response not specified) and 
that significant elevations in AVP and osmolality were dem-
onstrated in ten dehydrated subjects performing treadmill-
walking while deprived of fluid intake over 90 min in the 
heat (Maresh et al. 2004). No rise in osmolality was shown 
when same ten subjects performed the protocol in the euhy-
drated state while taking water ad libitum. Thus a minimum 
sample size of 12 volunteers was considered adequate to 
mitigate the occurrence of type 2 statistical errors in respect 
of changes in copeptin and osmolality.
Statistical methods
Statistical calculations were performed using the software 
package GraphPad Prism (GraphPad Prism version 5.01 
for Windows, GraphPad Software, San Diego California 
USA). Parametric or non-parametric statistical tests were 
applied after exploring the data for normality using the 
Shapiro–Wilk test. Changes in two-group paired continu-
ous data before and after the assault were analysed by Stu-
dent’s paired t test or Wilcoxon signed ranks test for para-
metric and non-parametric data, respectively. For unpaired 
two-group comparisons of parametric and non-parametric 
data an unpaired t test and a Mann–Whitney test were used, 
respectively. Relationships between copeptin, osmolality and 
normetanephrine responses were assessed using Pearson’s 
(parametric data) and Spearman’s (non-parametric data) 
coefficients. For the reasons outlined above, Tc of 38.0 °C 
is a thermal threshold with physiological and occupational 
relevance, so an exploratory analysis was performed for 
the effects of the field assault (PRE to POST) against Tc 
group using two-way repeated measures analysis of variance 
(ANOVA). Sidak’s multiple comparisons test was applied 
where appropriate. Individuals were assigned to Tc group 
according to whether the maximum temperature attained 
during the assault was > 38.0  °C (GT38) or ≤ 38.0  °C 
(LT38). The effect of Tc group on each biochemical param-
eter was expressed as Cohen’s d = (mean  changeGT38 −mean 
 changeLT38)/pooled standard deviation (SD), where pooled 
SD = √((SDGT382 + SDLT382)/2). Thermal (tempera-
ture–time) curves were also plotted, taking a normal resting 
Tc of 37 °C as the baseline above which the area under the 
curve (AUC-Tc37) was calculated. Data are presented as 
mean ± SD, except where specified. Data on Tc response are 
provided for the telemetric pill that had been in situ for the 
longest period.
Results
Volunteer characteristics
Pre-deployment (UK) measures were as follows: age 
25 ± 5 years; height 1.79 ± 0.07 m; weight 77.5 ± 8.9 kg; 
body mass index 25.3 ± 2.1 kg m2. body fat 16.2 ± 3.3%.
Assault exposure
The ambient (dry bulb) temperature measured local to the 
training area increased from 20 to 27 °C during the hours of 
the simulated combat assault. The median distance covered 
from GPS measurements was 1781 (range 585–2265) m. The 
median moving speed was 1.3 km h−1 (range 0–5.8 km h−1).
Core temperature
Figure 1 presents the group Tc response before, during 
and after the field assault. Group Tc ranged from a mini-
mum value (TcMin) of 36.8 ± 0.2 °C to a maximum value 
(TcMax) of 38.1 ± 0.4 °C, a rise of 1.3 °C (95% CI 1.2–1.5 °C, 
P < 0.0001). The highest individual Tc recorded was 38.7 °C 
and the greatest individual rise in Tc was 1.9 °C. Eight vol-
unteers attained TcMax ≥ 38.0 °C, spending 48 ± 20 min at 
or above this threshold, whereas Tc remained ≤ 38.0 °C in 
seven volunteers. The rise in Tc for GT38 (1.5 ± 0.3 °C) was 
higher compared with the LT38 group (1.2 ± 0.1 °C, 95% CI 
0.1–0.6 °C for the difference in maximal Tc change between 
GT38 and LT38).
Body mass
Clothed body mass decreased from 77.1 ± 8.2 kg PRE to 
75.9 ± 8.1 kg POST (95% CI −1.69 to −0.66 kg for the 
difference in clothed body mass). In GT38 vs. LT38, the 
change in clothed body mass did not differ in either abso-
lute (−1.4 ± 1.0 kg vs. −0.9 ± 0.8) or relative (−1.8 ± 1.4 vs. 
−1.2 ± 1.1%) terms.
Biochemical results
Between PRE and POST, there was a rise in copeptin 
(10.0 ± 6.3 vs. 16.7 ± 9.6 pmol L−1, P < 0.001), norme-
tanephrine (350 ± 157 vs. 576 ± 169, P < 0.0001) and sCr 
(98 ± 11 vs. 104 ± 15, P < 0.005), whereas cortisol decreased 
(620 ± 132 vs. 323 ± 125, P < 0.0001) and plasma osmolal-
ity did not change (291 ± 4 vs. 292 ± 4, P = 0.6074). Sweat 
sodium POST was 37 ± 12 mmol L−1.
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An association between copeptin and osmolality PRE 
(r = 0.46, P = 0.08) was strengthened POST (r = 0.70, 
P < 0.01; Fig.  2). The change in copeptin from PRE to 
POST (Δ copeptin) correlated positively with Δ creatinine, 
whereas its showed no significant association with Δ cor-
tisol, Δ normetanephrine or Δ osmolality. There was also 
a strong correlation between Δ copeptin and AUC-Tc37 
(r = 0.78, P < 0.01; Fig. 2) but no significant association 
between Δ copeptin and Δ body mass (Table 1).
From two-way ANOVA for repeated measures (Time by 
Tc), significant interactions existed for changes in copeptin 
(interaction F = 13.09, P < 0.05) and sCr (F = 9.7, P < 0.01), 
but not for cortisol, normetanephrine or osmolality (Fig. 3). 
For GT38 only, significant changes were observed for Δ 
copeptin (GT38 vs. LT38: 10.4 vs. 2.4 pmol L−1, 95% CI of 
difference 6.6 to 14.2 vs. −1.7 to 6.5 pmol L−1) and Δ sCr 
(GT38 vs. LT38: 10 vs. 2 μmol L−1, 95% CI of difference 6 
to 15 vs. −3 to 6 μmol L−1). This represented effect sizes of 
1.9 and 1.6 for higher Tc group (GT38 vs. LT38) on copeptin 
and sCr, respectively. In contrast, normetanephrine increased 
in both groups (GT38 vs. LT38: 275 vs. 169 pmol L−1, 95% 
CI of difference 167–383 vs. 54–285 pmol L−1, effect size 
0.9), cortisol decreased in both groups (GT38 vs. LT38: 
−247 vs. −354 nmol L−1, 95% CI of difference −357 to 
−136 vs. −472 to −236 nmol L−1, effect size 0.9) and 
osmolality did not change in either group (GT38 vs. LT38: 
2 vs. −1 mosm kg−1, 95% CI of difference −2 to 6 vs. −5 to 
3 mosm kg−1, effect size 0.7). In those in whom sweat sam-
ples were available, GT38 (n = 6) vs. LT38 (n = 4) tended to 
have a higher sweat sodium but this did not reach statistical 
significance (42.5 vs. 28.8 mmol L−1, 95% CI of difference 
28.1 to −0.6 mmol L−1, effect size 1.5).
Discussion
This is the first study to investigate relationships between 
copeptin and Tc responses. The principal finding of the study 
was that both copeptin and sCr discriminated groups by 
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Fig. 1  Core temperature (Tc) response recorded during simulated 
field assault, 8.00  a.m.–11.30  a.m. Top: 8 volunteers with maxi-
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TcMax, showing significant changes for GT38 but not LT38. 
Despite a rise in normetanephrine across the assault expo-
sure and evidence of a strong relationship between copeptin 
and osmolality, changes in cortisol, normetanephrine and 
osmolality did not reflect TcMax as well as copeptin and sCr. 
As described in the introduction, copeptin has been found to 
be of prognostic value in various conditions such as sepsis 
(Seligman et al. 2008), septic and haemorrhagic shock (Mor-
genthaler et al. 2007), in lower respiratory tract infections 
(Müller et al. 2007), heart failure (Stoiser et al. 2006) and 
myocardial infarction (Marston et al. 2016). We report for 
the first time an initial association between increased copep-
tin and higher physiological strain under thermal stress.
During submaximal exercise in the heat, osmolality is 
known to increase in proportion to the reduction in total 
body water from evaporative sweating. This has been shown 
to impair mechanisms involved in the dissipation of body 
heat, even in the presence of high aerobic fitness or advanced 
acclimatisation status (Cadarette et al. 1984; Fortney et al. 
1984; Sawka et  al. 1983). Osmolality and AVP couple 
closely following submaximal exercise in a hot laboratory 
environment—despite varying hydration, exercise intensity 
and Tc response (Montain et al. 1997)—and before and after 
prolonged submaximal running in a hot field environment 
(Mudambo et al. 1997). Significant relationships have also 
been reported between copeptin and osmolality, both at rest 
(Szinnai et al. 2007) and after prolonged endurance running 
(Bracher et al. 2012). In the present study, the strong asso-
ciation between copeptin and osmolality POST (r = 0.70, 
P = 0.004) indicated a persistent relationship between AVP 
and osmolality in the warm field environment.
Although threshold osmolality for AVP release shows 
marked inter-individual variation and may rarely exceed 
290 mosm kg−1  H2O, it is expected that osmotic stimulus 
to copeptin release existed in the majority of volunteers 
during the assault. Comparison of the regression lines for 
copeptin and osmolality (PRE vs. POST) however sug-
gested a change in the nature of the relationship between 
copeptin and osmolality over the course of the expo-
sure. The increase in copeptin was 0.83 pmol L−1 per 
unit increase in osmolality PRE, but almost doubled to 
1.64 pmol L−1 per mosm kg−1  H2O POST. The PRE rela-
tionship was not significant but did represent an important 
tendency (r = 0.46, P = 0.08, n = 15), where it is specu-
lated that rise in Tc increased the sensitivity for osmotic 
release of AVP/copeptin from PRE to POST. This would 
be consistent with laboratory observations of the effect of 
passive heating upon the relationship between AVP and 
osmolality (Takamata et al. 1995), whereby Tc rise of up 
to 1.0 °C progressively augmented AVP secretion above 
a threshold osmolality of 290 mosm kg−1. This mecha-
nism could also account for increases in copeptin without 
significant elevation in osmolality observed for the GT38 
group. The relationship of copeptin response to Tc excur-
sion is further supported by the strong correlation shown 
between Δ copeptin and AUC-Tc37 (r = 0.78, P = 0.0007).
The finding that sweat sodium tended to be higher in 
GT38 argues against osmotic stimulation being the only 
significant driver of copeptin response in this study, as rela-
tively higher sweat tonicity would diminish the rise in serum 
osmolality from hypotonic sweat losses. Rather, our results 
confirm the advancing acclimatisation status of the volun-
teers—with group sweat sodium measures being in the lower 
part of the expected range—and raise the possibility that 
copeptin responses may have reflected differences in the rate 
of heat adaptation between GT38 and LT38, with LT38 hav-
ing lesser copeptin response while appearing better adapted 
both by Tc and sweat sodium concentration.
An alternate or complementary explanation for the 
reported findings is that true ‘non-osmotic’ secretion of 
AVP and copeptin occurred. When Maresh et al. (2004) 
assessed the effect of drinking ad libitum upon osmolality 
and AVP responses during low-intensity exercise in a warm 
laboratory environment, significant AVP release was evi-
dent despite unchanged osmolality (~ 287 mosm kg−1 H2O) 
and only 1% loss of body mass across a 90 min exposure. 
It was suggested that non-osmotic peripheral secretion of 
AVP occurred secondary to activation of the sympathetic 
nervous system. Mellor et al. (2015) showed a rise in copep-
tin with exercise under progressively more stressful condi-
tions during a high altitude trek. As for AVP this occurred 
independently of osmolality, but whereas increasing altitude 
(and physiological stress) was shown to have an effect on 
copeptin response, the corollary was not significant for AVP. 
This disparity may have reflected known difficulties in the 
assay of AVP; it is also possible that copeptin better reflected 
non-osmotic stimuli, including headache, nausea, anxiety 
and stress from exertion in conditions of hypobaric hypoxia.
Table 1  Association of Δ copeptin (PRE to POST) with correspond-
ing changes in other parameters among 15 volunteers undergoing 
simulated field assault
Tc core temperature, AUC-Tc37 area under the curve (temperature–
time), baseline Tc = 37 °C
a Spearman r
b Pearson r
r P value
Maximum Δ Tc (°C) 0.47a 0.08
AUC-Tc37 (°C min−1) 0.78b < 0.01
Body mass (kg) −0.38b 0.16
Δ Cortisol (nmol L−1) 0.40b 0.14
Δ Normetanephrine (pmol L−1) 0.30a 0.27
Δ Osmolality (mosm kg−1) 0.40b 0.14
Δ Creatinine (μmol L−1) 0.61b 0.02
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In the present study, assay of plasma free norme-
tanephrine was undertaken to provide information about 
changes in sympathetic outflow and norepinephrine metab-
olism (Deutschbein et al. 2010; Woods et al. 2017). As a 
means of assessing sympathoadrenal activation during 
exercise in field conditions, this approach may have avoided 
certain pitfalls associated with norepinephrine measurement, 
relating to changes in posture or stress stimuli proximal to 
collection. Whereas an interaction between time and Tc 
group existed for copeptin responses, no such relationship 
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Fig. 3  Responses in GT38 and LT38 groups, for plasma copep-
tin, serum cortisol, plasma normetanephrine, serum osmolality and 
serum creatinine (before, PRE, and after, POST, field assault) and 
sweat sodium (POST assault). *Significant difference PRE to POST 
(P < 0.05), by Holm–Sidak multiple comparisons test
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was demonstrated for the normetanephrine or cortisol during 
the exposure. This finding would favour a genuine enhanced 
secretion of AVP/copeptin in consequence of greater relative 
thermal strain, rather than from more general stress asso-
ciated with sympathoadrenal stimulation. Indeed, while 
copeptin has been found to rise after prolonged endurance 
exercise (over 160 km endurance races) (Hew-Butler et al. 
2011) the GPS and cortisol data show that the exercise 
undertaken in our study was far from intense, and unlikely 
to explain the changes seen. And despite various other physi-
cal discomforts and psychological stressors that might be 
expected to serve as non-osmotic stimuli during simulated 
field combat, a clear interaction between training and Tc 
group was evident. These observations strengthen the sug-
gestion that copeptin may be of use in characterising physi-
ological strain under heat stress in particular and that the 
relationship warrants further investigation.
In addition to Tc rise, thermal strain encompasses the 
cardiovascular thermo-effector responses to exertion in a 
warm environment, which must meet the competing needs 
of increased blood supply to exercising muscle (metabolic 
demand) and skin (thermoregulation). These changes occur 
at the cost of blood flow to the kidneys and acute kidney 
injury is a well-recognised complication of severe heat ill-
ness (Leon and Bouchama 2015). The rise in sCr demon-
strated by GT38 may reflect greater thermoregulatory strain 
relative to LT38, and it is possible that reduced renal blood 
flow and glomerular filtration rate (GFR) contributed to 
the differential copeptin response between the two groups. 
The robust correlation between copeptin and sCr supports 
this alternate hypothesis. Interestingly, recent work using 
the synthetic analogue of AVP, desmopressin, has also sug-
gested a potential role for AVP in inducing chronic kidney 
disease following recurrent heat stress in mice (Roncal-
Jimenez et al. 2016). It is also therefore possible that what 
we have seen in association with GT38 could reflect a patho-
physiological mechanism to cause impaired kidney function 
in humans with thermal stress. Chronic kidney disease is 
epidemic among workers subject to dehydration in hot agri-
cultural environments (Bodin et al. 2016), with one recent 
investigation showing an increased risk of acute kidney 
injury from higher thermal strain during shifts in the field 
(Moyce et al. 2017). The mean maximum Tc in that larger 
sample was 38 °C.
While copeptin measurement presently requires the use 
of laboratory-based assay platforms, no more than 50 μL of 
sample is required, no extraction step is needed and results 
can be ready in as little as 30 min (Morgenthaler 2012). 
This suggests that point-of-care assay will be feasible in the 
near future. In the meantime, the stability of the molecule 
(stable for ≥ 7 days at room temperature) reduces the logis-
tics required for sample transfer from field/working environ-
ments to the laboratory, such that copeptin assay could be 
used to further investigate cumulative physiological strain 
in relation to next-day working practices and prevention of 
heat-related illnesses.
We acknowledge several limitations to our study. In the 
austere environment in which it was conducted we were 
unable to accurately measure changes in plasma volume. In 
addition to increased production and impaired clearance, a 
reduction in plasma volume from pre to post could further 
account for elevated plasma copeptin and sCr. However, it 
would seem unlikely to explain the 400–500% differences 
in copeptin and sCr responses between GT38 and LT38. In 
addition, the temporal relationships of the reported biochem-
ical parameters to other aspects of the field assault should be 
addressed. In order to undertake study measures in a field 
setting with the necessary standardisation and control, the 
investigators co-located with volunteers during the ‘live-fir-
ing’ phase of a busy infantry training exercise. Geographi-
cal and time constraints necessitated pre sampling being 
completed 5 h before the start of the field assault, though 
volunteers did not engage in strenuous physical exertion and 
were exposed to much cooler environmental temperatures 
in the intervening period (3.00 a.m.–8.00 a.m.), such that 
peak Tc remained below the level observed during the field 
assault. The advantage of sampling volunteers shortly after 
rising was that pre results could be regarded as true ‘steady 
state’ values, which would otherwise be impossible to obtain 
during a military deployment of this kind. The subsequent 
change in copeptin reflected the stressors of the intervening 
period rather than circadian rhythmicity, as copeptin does 
not synchronise with the light–dark cycle in healthy humans 
(Darzy et al. 2010). While we report greater rises in copeptin 
in GT38 vs. LT38, suggesting that copeptin reflects thermal 
strain, there were no cases of heat illness in our cohort. As 
the participants followed an appropriate period of acclima-
tisation and exertion levels were modest this is as expected. 
Further, it would have been unethical to specifically aim to 
induce heat casualties. Cardiovascular strain—which may 
also contribute to collapse during thermal stress—was not 
measured directly and further work is required to determine 
how this and other relevant factors, such as inflammatory 
responses, relate to copeptin and whether a single measure-
ment of copeptin might have diagnostic/prognostic value at 
higher levels of heat strain and in heat illness cases.
In conclusion, the change in copeptin reflected Tc 
response according to the occupational and physiological 
threshold of Tc = 38 °C, with over a fourfold greater rise in 
GT38 vs. LT38. The post-exercise coupling between copep-
tin and osmolality appeared to persist in the warm training 
environment, but may have been modified by changes in the 
osmotic sensitivity of AVP/copeptin release due to heating, 
as well as by changes in GFR. It is suggested that copeptin 
may be of future utility in assessing health risks associated 
with working under thermal stress, with potential to reflect 
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global physiological strain and possibly also pathophysio-
logical mechanisms contributing to heat-related morbidity. 
A point-of-care assay for copeptin would afford opportunity 
for in-field evaluation of a potential marker of integrated 
physiological strain alongside more conventional thermal 
stress monitoring. Further work is required to delineate the 
copeptin response to greater thermal stress both in health 
and ultimately in heat-related illnesses, as well as the effects 
of hydration and acclimatisation status.
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